Body composition in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitors |
08/17/2022 - 8:30am to 9:00am EDT |
" SYK of Chronic GVHD: A Novel Therapeutic Approach Targeting Aberrant B Cell Signaling with Fostamatinib” |
08/17/2022 - 8:00am to 9:00am EDT |
Hematology Oncology Grand 2022 |
08/10/2022 - 8:00am to 9:00am EDT |
"Identification of an optimal mutant allele frequency in cell-free DNA to predict sensitivity for actionable driver mutations in colorectal and pancreatic adenocarcinoma", “LRP1b as an indicator for sensitivity to immunotherapy” |
08/03/2022 - 8:00am to 9:00am EDT |
ctDNA Detection in Patients with Solid Tumors and Known Brain Metastases: A Duke Experience/Activity of the Tumor-intrinsic NLRP3 Inflammasome Pathway Predicts for Response to Checkpoint Inhibitor Immunotherapy in Melanoma Patients” |
07/27/2022 - 8:00am to 9:00am EDT |
Hematology Oncology Grand 2022 |
07/20/2022 - 8:00am to 9:00am EDT |
Believing in Science but Trusting Your Gut/Pittsburgh, People, and Prostates |
07/13/2022 - 8:00am to 9:00am EDT |
Hematology Oncology Grand 2022 |
07/06/2022 - 8:00am to 9:00am EDT |
Hematology Oncology Grand 2022 |
06/29/2022 - 8:00am to 9:00am EDT |
Annual Program Overview |
06/22/2022 - 8:00am to 9:00am EDT |